Intuitive Surgical, Inc. $ISRG Shares Acquired by Arete Wealth Advisors LLC

Arete Wealth Advisors LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.8% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,191 shares of the medical equipment provider’s stock after purchasing an additional 283 shares during the quarter. Arete Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $1,086,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Castleark Management LLC raised its position in shares of Intuitive Surgical by 3.4% in the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock worth $47,221,000 after buying an additional 2,990 shares during the period. Arlington Trust Co LLC raised its position in shares of Intuitive Surgical by 34.5% in the 1st quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider’s stock worth $369,000 after buying an additional 191 shares during the period. Aveo Capital Partners LLC raised its position in shares of Intuitive Surgical by 37.4% in the 1st quarter. Aveo Capital Partners LLC now owns 727 shares of the medical equipment provider’s stock worth $390,000 after buying an additional 198 shares during the period. Aaron Wealth Advisors LLC raised its position in shares of Intuitive Surgical by 3.2% in the 1st quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider’s stock worth $1,243,000 after buying an additional 78 shares during the period. Finally, Longbow Finance SA raised its position in shares of Intuitive Surgical by 132.0% in the 1st quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider’s stock worth $9,756,000 after buying an additional 11,209 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Down 0.5%

Shares of ISRG stock opened at $467.54 on Wednesday. The business has a 50 day moving average of $491.12 and a two-hundred day moving average of $510.92. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The company has a market cap of $167.60 billion, a P/E ratio of 65.21, a PEG ratio of 4.93 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the previous year, the firm posted $1.78 earnings per share. Intuitive Surgical’s quarterly revenue was up 21.4% compared to the same quarter last year. Analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have commented on ISRG. Citigroup reaffirmed a “buy” rating and set a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, July 26th. Evercore ISI lifted their target price on Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research report on Tuesday, July 8th. Finally, Wells Fargo & Company lifted their target price on Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 23rd. Thirteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $595.95.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Amy L. Ladd sold 336 shares of the business’s stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the transaction, the director owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 45,224 shares of company stock worth $21,716,492. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.